Nordwand Advisors’s Immuneering IMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,000
Closed -$2.56K 155
2024
Q2
$2.56K Buy
+2,000
New +$2.56K ﹤0.01% 137